Search for:
Category

Singapore

Category

On 20 July 2022, the Health Sciences Authority announced that it had removed over 2,500 listings of illegal health products from local e-commerce and social media platforms between January to June 2022, with over 800 product listings removed during a week of intensified surveillance between 23 and 30 June.

Singapore state investor Temasek, through its Asia Sustainable Foods Platform (ASF), and Cremer, a German agri-food multinational company, have jointly invested SGD 6 million to produce plant-based alternative proteins in Tuas, Singapore.
ASF and Cremer have formed the joint venture, Cremer Sustainable Foods, which will carry out pilots and demo-scale facilities for the joint venture’s first Singapore production facility.

To facilitate better traceability and follow-up actions in the event of safety or quality issues, the Health Science Authority (HSA) is launching a voluntary notification initiative for health supplements and traditional medicines. From 1 August 2022, companies may submit documents regarding their products to the HSA. If the products meet the necessary safety and quality standards and labelling requirements, they will be published on the HSA’s database, which patients and consumers can refer to when considering suitable health supplements and traditional medicines.

In May 2022, the Singapore Personal Data Protection Commission published a guide to help organisations collect, use or disclose individuals’ biometric data in a responsible manner. With security applications like security cameras and Closed-Circuit Television Cameras becoming increasingly commonplace, there have been more cases of organisations mishandling individuals’ biometric data. The release of this guide serves as a timely reminder for organisations to review their existing measures or implement new measures to ensure that they are dealing with individuals’ biometric data in a responsible manner.

In April 2022, the Health Sciences Authority published its revised Regulatory Guidelines for Software Medical Devices. It has also finalised its new Guidelines on Risk Classification of Standalone Medical Mobile Applications and Qualification of Clinical Decision Software, which had been released for public consultation in July to August 2021.

Given the increasing popularity of direct-to-consumer genetic testing, the Ministry of Health has taken various initiatives to raise awareness of the risks arising from the use of such tests. In addition to various social media advertisements since December 2021 and issuing an advisory for consumers in August 2021, the MOH also issued a guidance document for providers of non-clinical genetic testing in May 2021.